Benefit of salvage total pharyngolaryngoesophagectomy for recurrent locally advanced head and neck cancer after radiotherapy

被引:9
|
作者
Liu, Jie [1 ]
Zhang, Ye [2 ]
Li, Zhengjiang [1 ]
Liu, Shaoyan [1 ]
Li, Huizheng [3 ]
Xu, Zhengang [1 ]
机构
[1] Chinese Acad Med Sci, Peking Union Med Coll, Dept Head & Neck Surg Oncol, Natl Canc Ctr,Canc Hosp, 17 Panjiayuan Nanli,Head & Neck Ward 1, Beijing 100021, Peoples R China
[2] Chinese Acad Med Sci, Peking Union Med Coll, Dept Radiat Oncol, Natl Canc Ctr,Canc Hosp, Beijing, Peoples R China
[3] Dalian Friendship Hosp, Dept Otorhinolaryngol, Dalian, Peoples R China
来源
RADIATION ONCOLOGY | 2017年 / 12卷
关键词
SQUAMOUS-CELL CARCINOMA; PROGNOSTIC-FACTORS; RANDOMIZED-TRIALS; LARYNGEAL-CANCER; SURGERY; THERAPY; FAILURE; CHEMORADIATION;
D O I
10.1186/s13014-017-0900-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The treatment modalities for recurrent locally advanced head and neck cancer failure after radiotherapy are limited with poor prognosis. Salvage supra-radical operation seems to be an option. It has not been established which patients will benefit from salvage total pharyngolaryngoesophagectomy. Methods: We retrospectively reviewed 66 patients with previously irradiated recurrent T4 head and neck cancer who underwent salvage total pharyngolaryngoesophagectomy at our institution between January 2001 and June 2014. The clinical outcome and toxicities were analyzed. Results: Flap loss occurred in 2 patients, and the incidence of fistulas and anastomosis strictures was 15.6% (10/66) and 13.6% (9/66), respectively. The median survival time of the entire cohort was 12 months. The interval between radiation and salvage surgery, and microscopic carotid artery invasion were identified as independent prognostic factors for overall survival. The 3-year overall survival rates of patients with (n = 33) and without (n = 33) risk factors were 9.1% and 47.2%, respectively (p = 0.007). A time interval between radiation and salvage surgery <= 6 months and previous concurrent chemotherapy or targeted therapy were risk factors for severe post-operative complications. Conclusions: Salvage total pharyngolaryngoesophagectomy is beneficial to selected patients with recurrent locally advanced head and neck cancer after radiotherapy.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Benefit of salvage total pharyngolaryngoesophagectomy for recurrent locally advanced head and neck cancer after radiotherapy
    Jie Liu
    Ye Zhang
    Zhengjiang Li
    Shaoyan Liu
    Huizheng Li
    Zhengang Xu
    Radiation Oncology, 12
  • [2] Hypothyroidism after Radiotherapy of Locally Advanced Head and Neck Cancer
    Lee, Jeong Eun
    Kim, Jae-Chul
    Yea, Ji Woon
    Park, In Kyu
    RADIATION ONCOLOGY JOURNAL, 2010, 28 (02): : 64 - 70
  • [3] Salvage Stereotactic Body Radiotherapy for Locally Recurrent Head and Neck Carcinomas
    Cengiz, M.
    Ozyigit, G.
    Karakaya, E.
    Dogan, A.
    Beyaz, H.
    Yildiz, F.
    Akyol, F.
    Gurkaynak, M.
    Zorlu, F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S674 - S674
  • [4] Patterns of failure after postoperative intensity-modulated radiotherapy for locally advanced and recurrent head and neck cancer
    Ooishi, Mitsutoshi
    Motegi, Atsushi
    Kawashima, Mitsuhiko
    Arahira, Satoko
    Zenda, Sadamoto
    Nakamura, Naoki
    Ariji, Takaki
    Tokumaru, Sunao
    Sakuraba, Minoru
    Tahara, Makoto
    Hayashi, Ryuichi
    Akimoto, Tetsuo
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2016, 46 (10) : 919 - 927
  • [5] Salvage Stereotactic Reirradiation and Cetuximab for Locally Recurrent Head and Neck Cancer
    Comet, B.
    Faivre-Pierret, M.
    Coche-Dequeant, B.
    Degardin, M.
    Lefebvre, J. L.
    Lacomerie, T.
    Lartigau, E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S429 - S429
  • [6] Salvage of Locally Recurrent Prostate Cancer After Definitive Radiotherapy
    Mendenhall, William M.
    Henderson, Randal H.
    Hopp, Bradford S.
    Nichols, Romaine C.
    Mendenhall, Nancy P.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2014, 37 (04): : 411 - 416
  • [7] SYNCHRONOUS RADIOTHERAPY AND CHEMOTHERAPY WITH CISPLATIN IN THE MANAGEMENT OF LOCALLY ADVANCED OR RECURRENT HEAD AND NECK-CANCER
    GASPARINI, G
    RECHER, GF
    TESTOLIN, A
    DALFIOR, S
    PANIZZONI, GA
    CRISTOFERI, V
    SQUAQUARA, R
    POZZA, F
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1992, 15 (03): : 242 - 249
  • [8] SALVAGE REIRRADIATON WITH STEREOTACTIC BODY RADIOTHERAPY FOR LOCALLY RECURRENT HEAD-AND-NECK TUMORS
    Cengiz, Mustafa
    Ozyigit, Gokhan
    Yazici, Gozde
    Dogan, Ali
    Yildiz, Ferah
    Zorlu, Faruk
    Gurkaynak, Murat
    Gullu, Ibrahim H.
    Hosai, Sefik
    Akyol, Fadil
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (01): : 104 - 109
  • [9] Locally advanced head and neck cancer: chemoradiotherapy or acceleration of radiotherapy?
    Mazeron, Jean-Jacques
    BULLETIN DU CANCER, 2012, 99 (10) : 901 - 902
  • [10] Radiotherapy combined with Cetuximab for locally advanced head and neck cancer
    Acevedo-Henao, C-M
    Valette, G.
    Marianowski, R.
    Pradier, O.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2011, 187 : 96 - 96